Literature DB >> 17659688

Placebo responses in patients with gastrointestinal disorders.

Frauke Musial1, Sibylle Klosterhalfen, Paul Enck.   

Abstract

Over the last several years there has been a growing interest in placebo, not only as an inert control in clinical trials, but also in the placebo effect as a group effect as well as a reaction in individual subjects. Methodological factors such as regression to the mean and natural history of the disease play a role in the evaluation of a possible placebo effect. In this report, we discuss several factors including Pavlovian conditioning, beliefs outcome, expectations, and other factors as potential mediators of the placebo response. Placebo effects are common in gastrointestinal diseases and there seems to be no clear difference between placebo effects in functional gastrointestinal diseases (functional dyspepsia and irritable bowel syndrome) and organic gastrointestinal disease (duodenal ulcer and inflammatory bowel disease).

Entities:  

Mesh:

Year:  2007        PMID: 17659688      PMCID: PMC4146777          DOI: 10.3748/wjg.v13.i25.3425

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  48 in total

1.  Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies.

Authors:  H D Allescher; A Böckenhoff; G Knapp; M Wienbeck; J Hartung
Journal:  Scand J Gastroenterol       Date:  2001-09       Impact factor: 2.423

Review 2.  A systematic review of alternative therapies in the irritable bowel syndrome.

Authors:  Jennifer A Spanier; Colin W Howden; Michael P Jones
Journal:  Arch Intern Med       Date:  2003-02-10

Review 3.  Does how you do depend on how you think you'll do? A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes.

Authors:  M V Mondloch; D C Cole; J W Frank
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

4.  Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials.

Authors:  F Cremonini; S Delgado-Aros; M Camilleri
Journal:  Neurogastroenterol Motil       Date:  2003-02       Impact factor: 3.598

5.  Deconstructing the placebo effect and finding the meaning response.

Authors:  Daniel E Moerman; Wayne B Jonas
Journal:  Ann Intern Med       Date:  2002-03-19       Impact factor: 25.391

6.  The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation.

Authors:  Lene Vase; Michael E Robinson; G Nicholas Verne; Donald D Price
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

7.  Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients.

Authors:  G Nicholas Verne; Michael E Robinson; Lene Vase; Donald D Price
Journal:  Pain       Date:  2003-09       Impact factor: 6.961

8.  Validation of irritable bowel syndrome Global Improvement Scale: an integrated symptom end point for assessing treatment efficacy.

Authors:  Susan Gordon; Vanessa Ameen; Barbara Bagby; Britt Shahan; Priti Jhingran; Eric Carter
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

9.  Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression.

Authors:  Jeffrey A Welge; Paul E Keck
Journal:  Psychopharmacology (Berl)       Date:  2002-12-20       Impact factor: 4.530

10.  Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses.

Authors:  Fabrizio Benedetti; Antonella Pollo; Leonardo Lopiano; Michele Lanotte; Sergio Vighetti; Innocenzo Rainero
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

View more
  15 in total

1.  Transcutaneous electrical posterior tibial nerve stimulation for faecal incontinence: effects on symptoms and quality of life.

Authors:  Veronique Vitton; Vitton Veronique; Henri Damon; Damon Henri; Sabine Roman; Roman Sabine; François Mion; Mion François
Journal:  Int J Colorectal Dis       Date:  2010-06-04       Impact factor: 2.571

Review 2.  Hypnosis and upper digestive function and disease.

Authors:  Giuseppe Chiarioni; Olafur S Palsson; William E Whitehead
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

3.  [Is the analgesic effect of acupuncture a placebo effect?].

Authors:  F Musial; I Tao; G Dobos
Journal:  Schmerz       Date:  2009-08       Impact factor: 1.107

4.  Otilonium bromide in irritable bowel syndrome: a dose-ranging randomized double-blind placebo-controlled trial.

Authors:  Danuta Chmielewska-Wilkoń; Giorgio Reggiardo; Colin Gerard Egan
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  Association of Patient Belief About Success of Antibiotics for Appendicitis and Outcomes: A Secondary Analysis of the CODA Randomized Clinical Trial.

Authors:  Irene Y Zhang; Emily C Voldal; Giana H Davidson; Joshua M Liao; Callie M Thompson; Wesley H Self; Lillian S Kao; Jill Cherry-Bukowiec; Krishnan Raghavendran; Amy H Kaji; Daniel A DeUgarte; Eva Gonzalez; Katherine A Mandell; Kristen Ohe; Nicole Siparsky; Thea P Price; David C Evans; Jesse Victory; William Chiang; Alan Jones; Matthew E Kutcher; Hailie Ciomperlik; Mike K Liang; Heather L Evans; Brett A Faine; Miriam Neufeld; Sabrina E Sanchez; Anusha Krishnadasan; Bryan A Comstock; Patrick J Heagerty; Sarah O Lawrence; Sarah E Monsell; Erin E C Fannon; Larry G Kessler; David A Talan; David R Flum
Journal:  JAMA Surg       Date:  2022-10-05       Impact factor: 16.681

6.  Effect of probiotics on symptoms in korean adults with irritable bowel syndrome.

Authors:  Kyoung Sup Hong; Hyoun Woo Kang; Jong Pil Im; Geun Eog Ji; Sang Gyun Kim; Hyun Chae Jung; In Sung Song; Joo Sung Kim
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

7.  The effects of candesartan on diabetes glomerulopathy: a double-blind, placebo-controlled trial.

Authors:  Nina E S S Perrin; Georg A Jaremko; Ulla B Berg
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

8.  Changes in Metabolic Hormones in Malaysian Young Adults following Helicobacter pylori Eradication.

Authors:  Theresa Wan-Chen Yap; Alex Hwong-Ruey Leow; Ahmad Najib Azmi; Fritz Francois; Guillermo I Perez-Perez; Martin J Blaser; Bee-Hoon Poh; Mun-Fai Loke; Khean-Lee Goh; Jamuna Vadivelu
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

9.  Acupuncture for Functional Dyspepsia: A Single Blinded, Randomized, Controlled Trial.

Authors:  Yulian Jin; Qing Zhao; Kehua Zhou; Xianghong Jing; Xiaochun Yu; Jiliang Fang; Zhishun Liu; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-30       Impact factor: 2.629

10.  Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics.

Authors:  Andrea Shin; Michael Camilleri; Irene Busciglio; Duane Burton; Elizabeth Stoner; Patrick Noonan; Keith Gottesdiener; Steven A Smith; Adrian Vella; Alan R Zinsmeister
Journal:  Diabetes Care       Date:  2012-09-06       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.